GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (OTCPK:XTXXF) » Definitions » Altman Z-Score

XTXXF (Adastra Holdings) Altman Z-Score : -0.74 (As of Dec. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Adastra Holdings Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -0.73 is in distress zone. This implies bankruptcy possibility in the next two years.

Adastra Holdings has a Altman Z-Score of -0.74, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Adastra Holdings's Altman Z-Score or its related term are showing as below:

XTXXF' s Altman Z-Score Range Over the Past 10 Years
Min: -0.73   Med: 2.19   Max: 11.56
Current: -0.73

During the past 5 years, Adastra Holdings's highest Altman Z-Score was 11.56. The lowest was -0.73. And the median was 2.19.


Adastra Holdings Altman Z-Score Historical Data

The historical data trend for Adastra Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings Altman Z-Score Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
- 7.16 4.70 -0.34 -0.34

Adastra Holdings Quarterly Data
Oct18 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.15 -0.34 -0.56 -0.62

Competitive Comparison of Adastra Holdings's Altman Z-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adastra Holdings's Altman Z-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's Altman Z-Score falls into.



Adastra Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Adastra Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*-0.212+1.4*-0.7368+3.3*-0.0799+0.6*0.1067+1.0*0.7413
=-0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $22.95 Mil.
Total Current Assets was $7.55 Mil.
Total Current Liabilities was $12.41 Mil.
Retained Earnings was $-16.91 Mil.
Pre-Tax Income was 0.063 + -0.968 + -1.354 + -0.48 = $-2.74 Mil.
Interest Expense was -0.204 + -0.251 + -0.259 + -0.192 = $-0.91 Mil.
Revenue was 5.244 + 4.823 + 3.727 + 3.215 = $17.01 Mil.
Market Cap (Today) was $1.38 Mil.
Total Liabilities was $12.95 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(7.549 - 12.413)/22.945
=-0.212

X2=Retained Earnings/Total Assets
=-16.905/22.945
=-0.7368

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-2.739 - -0.906)/22.945
=-0.0799

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1.382/12.949
=0.1067

X5=Revenue/Total Assets
=17.009/22.945
=0.7413

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Adastra Holdings has a Altman Z-Score of -0.74 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Adastra Holdings  (OTCPK:XTXXF) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Adastra Holdings Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.